World Health Organization chief scientist Soumya Swaminathan said that they expect several hundred million COVID-19 vaccine doses to be produced by the end of 2020. By the end of 2021, it is aimed to produce 2 billion doses of vaccine.
The World Health Organization announced on Thursday that they aim to produce several hundred million COVID-19 vaccines by the end of the year. The vaccine, which is expected to be given to those who are considered to be the most vulnerable to the virus in the first place, will be increased to 2 billion doses by the end of 2021, according to projections.
WHO chief scientist Soumya Swaminathan stated that they are currently working on more than 200 vaccine candidates, 10 of which have started human testing. “If we are very lucky, there will be one or two successful candidates before the end of this year,” said Swaminathan, who said that the vaccine will be made to people who are vulnerable to COVID-19, such as the elderly and diabetics, along with people working in the frontline, such as paramedics and police officers.
Making the assumptions about the COVID-19 vaccine, where thousands of scientists are working towards mass production towards the end of 2020, Swaminathan said, “We should start with the most vulnerable people at the beginning and then vaccinate more people.” “We are working on the assumption that we can take several hundred million doses at the end of this year with an optimistic thought,” said Swaminathan, “We hope that there will be 1 to 3 effective vaccines in two billion doses that will spread to the world in 2021, but there is a great” if “here, because there is a proven we have no vaccine. ” said.
15 billion doses of vaccine required to completely stop the outbreak
Some pharmaceutical companies that have been working on the COVID-19 vaccine have said last month that the COVID-19 vaccine may start spreading before 2021, but about 15 billion doses are needed to stop the virus completely. The fact that the virus does not mutate, but does not mutate in key areas, is currently one of the most important points that relieve scientists.
Vaccine development for coronavirus continues in our country. Countries that will succeed in producing the vaccine, especially at a time when the economic structures of the countries have suffered so much, will also find a rapid rise after this difficult period. Because these vaccines will be purchased by all countries of the world for a certain fee.